HCAT
Get informed when a big investor buys or sells
+ FollowUndervalued by 70.3% based on the discounted cash flow analysis.
| Market cap | $125.62 Million |
|---|---|
| Enterprise Value | $125.69 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.55 |
| Beta | 1.53 |
| Outstanding Shares | 73,960,000 |
| P/E Ratio | -0.46 |
|---|---|
| PEG | 42.93 |
| Price to Sales | 0.57 |
| Price to Book Ratio | 1.7 |
| Enterprise Value to Revenue | 0.43 |
| Enterprise Value to EBIT | -0.79 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.48 |
| Debt to Equity | 0.6 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3414▼ 8.26% |
|---|---|
| Total Calls | 3,003,100▲ 21.16% |
| Total Puts | 1,025,400▼ 2.45% |
Holdings and activity of institutional investors.
| Ownership % | 71.48%▼ 5.42% |
|---|---|
| Total Invested | $105.21M▲ 48.36% |
| Investors Holding | 137▼ 2.00% |
No data